Advertise on podcast: FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
Rating
4.5from
This podcast has
111 episodes
Language
EnglishExplicit
No
Date created
2017/05/17
Latest episode
2024/01/08
Average duration
4 min.
Release period
26 days
Description
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) is an FDA podcast series that provides information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development.
Unlock FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details
Listeners
Audience numbers & engagement insights
Audience details
Podcast Insights
Podcast episodes
Check latest episodes from FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) podcast
FDA D.I.S.C.O. Burst Edition: FDA approval of OGSIVEO (nirogacestat) for adult patients with progressing desmoid tumors who require systemic treatment
2024/01/08
Listen to a soundcast of the November 27, 2023 FDA approval of OGSIVEO (nirogacestat) for adult patients with progressing desmoid tumors who require systemic treatment.
FDA D.I.S.C.O. Burst Edition: FDA approval of Augtyro (repotrectinib) for locally advanced or metastatic ROS1-positive non-small cell lung cancer
2024/01/05
FDA D.I.S.C.O. Burst Edition: FDA approval of Augtyro (repotrectinib) for locally advanced or metastatic ROS1-positive non-small cell lung cancer
FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with metastatic colorectal cancer
2024/01/05
FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with metastatic colorectal cancer
FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or refractory myelodysplastic syndromes with a susceptible isocitrate dehydrogenase-1 mutation
2023/11/20
FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or refractory myelodysplastic syndromes with a susceptible isocitrate dehydrogenase-1 mutation
FDA D.I.S.C.O. Burst Edition: FDA approvals of Talvey (talquetamab-tgvs) for relapsed or refractory multiple myeloma, and Elrexfio (elranatamab-bcmm) for relapsed or refractory multiple myeloma
2023/09/26
FDA D.I.S.C.O. Burst Edition: FDA approvals of Talvey (talquetamab-tgvs) for relapsed or refractory multiple myeloma, and Elrexfio (elranatamab-bcmm) for relapsed or refractory multiple myeloma
FDA D.I.S.C.O. Burst Edition: FDA approval of Lynparza (olaparib), with abiraterone and prednisone, for BRCA-mutated metastatic castration-resistant prostate cancer
2023/07/13
Listen to a soundcast of the May 31, 2023, FDA approval of Lynparza (olaparib), with abiraterone and prednisone, for BRCA-mutated metastatic castration-resistant prostate cancer.”
FDA D.I.S.C.O. Burst Edition: FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma
2023/06/21
Listen to a soundcast of the May 19, 2023, FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma.
FDA D.I.S.C.O. Burst Edition: FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma
2023/06/07
Listen to a soundcast of the April 19, 2023, FDA approval of Polivy (polatuzumab vedotin-piiq) for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma.
FDA D.I.S.C.O. Burst Edition: FDA approval of Omisirge (omidubicel-onlv) to reduce time to neutrophil recovery and infection in patients with hematologic malignancies
2023/05/25
Listen to a soundcast of the April 17, 2023, FDA approval of Omisirge (omidubicel-onlv) to reduce time to neutrophil recovery and infection in patients with hematologic malignancies.
FDA D.I.S.C.O. Burst Edition: FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) for locally advanced or metastatic urothelial carcinoma
2023/05/03
Listen to a soundcast of the April 19, 2023, FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) for locally advanced or metastatic urothelial carcinoma.”
FDA D.I.S.C.O. Burst Edition: FDA approval of Zynyz (retifanlimab-dlwr) for metastatic or recurrent locally advanced Merkel cell carcinoma
2023/04/20
Lsten to a soundcast of the March 22, 2023 FDA approval of Zynyz (retifanlimab-dlwr) for metastatic or recurrent locally advanced Merkel cell carcinoma.
FDA D.I.S.C.O. Burst Edition: FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation
2023/04/06
Listen to a soundcast of the March 16, 2023, FDA approval of Tafinlar (dabrafenib) for pediatric patients with low-grade glioma with a BRAF V600E mutation
Podcast reviews
Read FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) podcast reviews
ASCOmember 2018/08/18
Info on new cancer drugs
This is a very interesting podcast about important new drugs approved by FDA for cancer treatment.
Pharmasteve 2017/06/19
Great
This is the best.
Okeeydoke 2017/05/30
Excellent Addition to FDA Podcasts
Provides important, concise information in easily digestible format. Valuable tool for physicians & pharmacists staying abreast of new drug approvals ...
Podcast sponsorship advertising
Start advertising on FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) relevant audience podcasts
You may also like to advertise on these Podcasts
4.8499667
Celtics Beat
CLNS Media Sports Network
4.3180983
Global Seducer Podcast
Certified Dating Coach Reveals How to Attract Quality Women
4.9331300
Oh, My Health...There Is Hope!
Jana Short
4.6323275
Millennial Minimalists
Cloud10
3.7601285
Simon Calder's Independent Travel Podcast
The Independent
5148577
Small Changes Big Shifts
Dr. Michelle Robin
4.676114
The Andy Pollin Show
ESPN 630 DC | Cumulus Media Washington
4.728866
SafeGuardYourSoul Podcast with Todd Tomasella
Todd Tomasella
4.927999
The Strong Life Project Podcast
Shaun O'Gorman: Human Behaviour & High Performance Coach
4.8234358
It's About Time | Time Management & Productivity for Work Life & Balance
Anna Dearmon Kornick